Our paper is out, finally. Congratulations to first authors, Ritika Tiwari & Nishat Manzar, coauthors, collaborators Nallasivam Palanisamy Misha Beltran @AminaZoubeidi Francesca Khani, MD. Thanks to DBT/WT India Alliance for funding. Thanks Department of Biotechnology SERB IIT Kanpur nature.com/articles/s4146…

Thanks to all authors for contributing to this story: "Androgen deprivation upregulates SPINK1 expression and potentiates cellular plasticity in prostate cancer". Congratulations to all authors Ritika Tiwari Nishat Manzar Vipul Bhatia Thanks DBT/WT India Alliance for funding this work.

Androgen deprivation upregulates SPINK1 expression and potentiates cellular plasticity in prostate cancer. 𝙉𝙖𝙩 𝘾𝙤𝙢𝙢𝙪𝙣. Bushra Ateeq Ritika Tiwari Nishat Manzar Nallasivam Palanisamy Misha Beltran @AminaZoubeidi Francesca Khani, MD #ProstateCancer go.nature.com/2G9xkjK

Elevated levels of SPINK1 governs cellular plasticity and maintains neuroendocrine phenotype in prostate cancer. cancercommunity.nature.com/channels/465-b…

Where could we be going wrong in treating #ProstateCancer? How do we get better at it?👩‍⚕️ Find answers to these questions in latest #research by India Alliance fellow Bushra Ateeq at IIT Kanpur 👩‍🔬 Research summary🔗 indiaalliance.org/news/384 ✍️@kirangurung29 for Research Matters

Thanks to DBT/WT India Alliance for funding this work. Congratulations to Ritika Tiwari Nishat Manzar, coauthors, collaborators Nallasivam Palanisamy Misha Beltran @AminaZoubeidi Francesca Khani, MD and others A safer alternative to treat aggressive prostate cancer found thehindu.com/sci-tech/scien…

In this review, we discuss the role of genetic and epigenetic alterations as well as tumor microenvironment on cellular plasticity and drug resistant prostate cancer. Thanks to Mohit Kumar Jolly for inviting us to write this piece. Ritika Tiwari Nishat Manzar frontiersin.org/articles/10.33…

Our recent work "Transcriptional network involving ERG and AR orchestrates Distal-Less Homeobox 1 mediated prostate cancer progression". Congratulations to first author, Sakshi Goel, Vipul Bhatia & collaborators Nallasivam Palanisamy Suggestions are welcome. biorxiv.org/content/10.110…

Please check the preprint of our recent work Bushra Ateeq Vipul Bhatia. The transcriptional regulation of homoeobox gene DLX1 and it's oncogenic role in prostate cancer. Suggestions are invited. biorxiv.org/content/10.110… biorxiv.org/content/10.110…

Excited to share our latest article about the role of AGTR1/NF-kB /CXCR4 signaling axis in Glioblastoma. Congratulations to Anukriti and coauthors !!! #Glioblastoma #Mirnaa #AGTR1 sciencedirect.com/science/articl…

What a proud moment for BSBE, IITK. Our wonderful colleague, Prof. Bushra Ateeq, brings home the 1st Bhatnagar Award to the department !!! We all are mighty proud of you Bushra !!! Bushra Ateeq

Excited to share our recent work in Nature Communications exploring DLX1-mediated prostate cancer. Heartiest Congratulations to super talented and hardworking first author Sakshi Goel, coauthors Vipul Bhatia Sushmita Kundu, Tanay Biswas and collaborators. nature.com/articles/s4146…

1/11 Incredibly excited about our story PNASNews just out on an H3K9 #epigenetic driver of enzalutamide resistance, viral mimicry and a blazing interferon (IFN) response in #prostatecancer led by superstars Mehdi Baratchian & Ritika Tiwari doi.org/10.1073/pnas.2…

Postdoctoral Fellow - Molecular Mechanisms and Translational Oncology | Nature Careers ⁦The PostDocs Forum⁩ ⁦Nature Careers⁩ #metabolism #steroids nature.com/naturecareers/…

👨‍⚕️ Dr. Nima Sharifi from Cleveland Clinic spoke with us about H3️⃣K9️⃣ methylation drives resistance to androgen receptor-antagonist therapy in 👭 with prostate cancer. Mehdi Baratchian Ritika Tiwari Cleveland Clinic MD #OncoTwitter @oncoalert 📺 bit.ly/3GPrXVo

hi everyone!!!!

‘Your cells don’t have the genome you were born with.’ science.org/content/articl…

#PCFRetreat25 PCF Science Antibody-Dynamite Conjugate Table#2 Roni Haas Peter Godolphin Galina Semenova Ramyar Molania Brad Gallent, MD, PhD

Hmmm....

twiitter needs something that facebook has.............;)